Related Experiment Videos
[Non-secretory myeloma syndrome]
F Pinto1, M Santonastaso, D Dannhäuser
1Unità Operativa di Medicina Interna, Ospedale Civile, Vittorio Veneto.
Recenti Progressi in Medicina
|September 13, 2001
Summary
Non secretory myeloma, a rare plasma cell disorder, lacks monoclonal proteins in blood and urine. Diagnosis relies on clinical signs, elevated PCR and beta-2 microglobulin, and bone marrow biopsy.
Area of Science:
- Hematology
- Oncology
Background:
- Non secretory myeloma is a rare subtype of multiple myeloma.
- It is characterized by the absence of monoclonal proteins in serum and urine.
Observation:
- Diagnosis can be challenging due to non-specific clinical presentations and lack of lytic bone lesions.
- Two cases are presented, highlighting diagnostic challenges and key findings.
Findings:
- Diagnostic indicators include absence of monoclonal component, elevated C-reactive protein (PCR), increased beta-2 microglobulin, and low serum immunoglobulin levels.
- Imaging like CT, MRI, and Tc-99 MIBI scans aid in assessing treatment response.
- Bone marrow biopsy confirms diagnosis through characteristic plasma cell infiltration.
Implications:
- Early and accurate diagnosis of non secretory myeloma is crucial for timely treatment.
- Monitoring treatment response requires methods beyond M-component quantification.
- Understanding diverse pathogenetic mechanisms is key for managing this rare myeloma variant.